Hematology / Oncology
Title
Date Published
Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis.
August 3, 2009
Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.
August 1, 2009
Anemia management in oncology and hematology
June 30, 2009
Treatment of MDS: something old, something new, something borrowed
June 30, 2009
Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.
June 25, 2009
Blood loss in surgical oncology: neglected quality indicator?
June 15, 2009
Review Article: Second-generation thrombopoietin agents for treatment of chronic idiopathic thrombocytopenic purpura in adults.
June 12, 2009
Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell disease.
March 1, 2009
An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach.
January 17, 2009
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.
November 11, 2008
HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).
September 1, 2008
Liposome-encapsulated hemoglobin transfusion rescues rats undergoing progressive hemodilution from lethal organ hypoxia without scavenging nitric oxide.
August 1, 2008
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
July 21, 2008
HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.
June 1, 2008
Inhaled nitric oxide enables artificial blood transfusion without hypertension.
April 15, 2008
Haemoglobin, oxygen carriers and perioperative organ perfusion.
March 22, 2008
Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working Group Workshop, March 1, 2006.
January 7, 2008
Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions.
November 27, 2007
An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: Current status/future trends.
November 23, 2007
Resuscitation from hemorrhagic shock comparing standard hemoglobin-based oxygen carrier (HBOC)-201 versus 7.5% hypertonic HBOC-201.
November 1, 2007